Insider Trading activities of Concert Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Concert Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Concert Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Concert Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is CNCE. The reporting company's CIK number is 1367920.
The total value of stock buying since 2005 is $23,600,770.
The total value of stock sales since 2005 is $27,802,933.
The total value of stock option exercises since 2005 is $553,349.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Concert Pharmaceuticals, Inc. (CNCE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 0 $0 11,555 $52,921
2017-10 331,916 $5,256,885 0 $0 0 $0
2017-09 0 $0 3,500 $50,785 3,500 $33,110
2017-03 0 $0 0 $0 33,064 $37,361
2016-12 0 $0 0 $0 7,100 $8,022
2016-11 0 $0 22,123 $217,026 22,123 $24,998
2016-05 19,610 $206,885 0 $0 0 $0
2016-01 0 $0 0 $0 26,000 $91,480
2015-12 0 $0 89,352 $1,783,799 498 $1,743
2015-11 0 $0 40,915 $959,139 53,715 $47,694
2015-09 0 $0 130,497 $2,395,830 22,497 $26,598
2015-08 0 $0 950,000 $14,974,105 0 $0
2015-06 0 $0 5,498 $89,768 498 $1,743
2015-03 0 $0 80,023 $1,187,481 80,023 $99,382
2015-02 0 $0 0 $0 28,495 $32,199
2014-11 0 $0 500,000 $6,145,000 0 $0
2014-05 0 $0 0 $0 90,000 $96,098
2014-02 1,295,500 $18,137,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Concert Pharmaceuticals, Inc. insiders (CNCE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-17 Tung Roger D (Chief Executive Officer) Option Ex 7,340 4.58 33,617
2017-11-14 Stuart Nancy (Chief Operating Officer) Option Ex 4,215 4.58 19,304
2017-10-19 Lampert Mark N Buy 331,916 15.84 5,256,885
2017-09-14 Lynch Ryan (PFO, PAO) Sale 3,500 14.51 50,785
2017-09-14 Lynch Ryan (PFO, PAO) Option Ex 3,500 9.46 33,110
2017-03-09 Silverman Robert (Senior VP, General Counsel) Option Ex 30,966 1.13 34,991
2017-03-08 Stuart Nancy (Chief Operating Officer) Option Ex 2,098 1.13 2,370
2016-12-06 Stuart Nancy (Chief Operating Officer) Option Ex 7,100 1.13 8,022
2016-11-14 Hutt Peter Barton (Director) Sale 22,123 9.81 217,026
2016-11-14 Hutt Peter Barton (Director) Option Ex 22,123 1.13 24,998
2016-05-11 Tung Roger D (Chief Executive Officer) Buy 19,610 10.55 206,885
2016-01-20 Silverman Robert (Senior VP, General Counsel) Option Ex 8,000 1.13 9,040
2016-01-11 Tung Roger D (Chief Executive Officer) Option Ex 18,000 4.58 82,440
2015-12-16 Three Arch Management Iv, L.l.c. (Director) Sale 10,360 19.57 202,703
2015-12-16 Aldrich Richard (Director) Sale 20,000 19.76 395,200
2015-12-15 Three Arch Management Iv, L.l.c. (Director) Sale 54,572 20.10 1,097,115
2015-12-14 Mcgowan Pauline (VP, Finance) Sale 498 20.07 9,996
2015-12-14 Mcgowan Pauline (VP, Finance) Option Ex 498 3.50 1,743
2015-12-14 Three Arch Management Iv, L.l.c. (Director) Sale 3,922 20.09 78,785
2015-11-11 Stuart Nancy (Chief Operating Officer) Option Ex 9,200 1.13 10,395
2015-11-09 Silverman Robert (Senior VP, General Counsel) Option Ex 3,600 1.13 4,067
2015-11-09 Barrett Ronald W (Director) Sale 17,699 22.32 395,130
2015-11-09 Barrett Ronald W (Director) Option Ex 17,699 1.13 19,999
2015-11-02 Stuart Nancy (Chief Operating Officer) Sale 23,216 24.29 564,009
2015-11-02 Stuart Nancy (Chief Operating Officer) Option Ex 23,216 .57 13,233
2015-09-18 Silverman Robert (Senior VP, General Counsel) Sale 10,000 20.00 200,000
2015-09-18 Silverman Robert (Senior VP, General Counsel) Option Ex 5,000 1.13 5,649
2015-09-14 Mcgowan Pauline (VP, Finance) Sale 497 18.98 9,430
2015-09-14 Mcgowan Pauline (VP, Finance) Option Ex 497 3.50 1,739
2015-09-14 Stuart Nancy (Chief Operating Officer) Option Ex 17,000 1.13 19,210
2015-09-10 Three Arch Management Iv, L.l.c. (Director) Sale 120,000 18.22 2,186,400
2015-08-18 Three Arch Management Iv, L.l.c. (Director) Sale 630,000 15.70 9,891,000
2015-08-14 Three Arch Management Iv, L.l.c. (Director) Sale 130,000 16.32 2,121,600
2015-08-13 Three Arch Management Iv, L.l.c. (Director) Sale 92,215 16.75 1,544,601
2015-08-12 Three Arch Management Iv, L.l.c. (Director) Sale 97,785 14.49 1,416,904
2015-06-12 Mcgowan Pauline (VP, Finance) Sale 498 16.08 8,008
2015-06-12 Mcgowan Pauline (VP, Finance) Option Ex 498 3.50 1,743
2015-06-08 Silverman Robert (Senior VP, General Counsel) Sale 5,000 16.35 81,760
2015-03-13 Mcgowan Pauline (VP, Finance) Sale 498 16.00 7,968
2015-03-13 Mcgowan Pauline (VP, Finance) Option Ex 498 3.50 1,743
2015-03-11 Mcgowan Pauline (VP, Finance) Sale 5,973 16.00 95,568
2015-03-11 Mcgowan Pauline (VP, Finance) Option Ex 5,973 3.50 20,905
2015-03-11 Silverman Robert (Senior VP, General Counsel) Sale 5,000 16.00 80,000
2015-03-11 Silverman Robert (Senior VP, General Counsel) Option Ex 5,000 1.13 5,649
2015-03-11 Stuart Nancy (Chief Operating Officer) Sale 46,430 15.00 696,450
2015-03-11 Stuart Nancy (Chief Operating Officer) Option Ex 46,430 .57 26,465
2015-03-10 Mcgowan Pauline (VP, Finance) Sale 22,122 13.90 307,495
2015-03-10 Mcgowan Pauline (VP, Finance) Option Ex 22,122 2.02 44,620
2015-02-17 Tung Roger D (Chief Executive Officer) Option Ex 28,495 1.13 32,199
2014-11-18 Three Arch Associates Iv Lp (10% Owner) Sale 250,000 12.29 3,072,500
2014-11-18 Jaeger Wilfred E (Director) Sale 250,000 12.29 3,072,500
2014-05-29 Silverman Robert (Senior VP, General Counsel) Option Ex 20,000 1.13 22,599
2014-05-29 Stuart Nancy (Chief Operating Officer) Option Ex 10,000 .57 5,699
2014-05-22 Tung Roger D (Chief Executive Officer) Option Ex 60,000 1.13 67,800
2014-02-20 Freund John Gordon (Director) Buy 150,000 14.00 2,100,000
2014-02-20 Kaneko Yasunori (10% Owner) Buy 150,000 14.00 2,100,000
2014-02-19 Qvt Fund V Lp (10% Owner) Buy 300,000 14.00 4,200,000
2014-02-19 Wan Mark A (10% Owner) Buy 207,000 14.00 2,898,000
2014-02-19 Glaxosmithkline Plc Buy 35,000 14.00 490,000
2014-02-19 Brookside Capital Partners Fund Lp (10% Owner) Buy 350,000 14.00 4,900,000

Insider trading activities including stock purchases, stock sales, and option exercises of CNCE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Concert Pharmaceuticals, Inc. (symbol CNCE, CIK number 1367920) see the Securities and Exchange Commission (SEC) website.